Vitamin D inhibition of the prostaglandin pathway as therapy for prostate cancer.
Feldman
David
D
Department of Medicine/Endocrinology, Stanford University School of Medicine, 300 Pasteur Drive, Room S-025, Stanford, CA 94305-5103, USA. feldman@cmgm.stanford.edu
Krishnan
Aruna
A
Moreno
Jacqueline
J
Swami
Srilatha
S
Peehl
Donna M
DM
Srinivas
Sandy
S
D006801:Humans; D008297:Male; D011448:Prostaglandin Antagonists / Q000494:pharmacology* / Q000627:therapeutic use; D011453:Prostaglandins / Q000378:metabolism*; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology*; D014807:Vitamin D / Q000494:pharmacology* / Q000627:therapeutic use
D011448:Prostaglandin Antagonists; D011453:Prostaglandins; D014807:Vitamin D